Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jiajian Guishen Formulation (JJGS) is a Traditional Chinese Medicine (TCM) herbal formulation primarily used to treat female reproductive disorders, including Premature Ovarian Insufficiency (POI) and Poor Ovarian Response (POR). It is a modified version of the classic 'Guishen Wan' formula, traditionally employed to 'tonify the kidney' and regulate the hypothalamic-pituitary-ovarian (HPO) axis. Clinical research, largely conducted by institutions such as the Beijing University of Traditional Chinese Medicine, has focused on its ability to improve ovarian reserve markers like Anti-Müllerian Hormone (AMH) and Antral Follicle Count (AFC), as well as its potential to enhance pregnancy outcomes in patients undergoing assisted reproductive technology. The formulation is typically administered as granules and is often studied in combination with other supplements like Coenzyme Q10.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jiajian Guishen Formulation.